Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies

scientific article published on 20 August 2018

Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/BS.IRCMB.2018.07.003
P932PMC publication ID6487201
P698PubMed publication ID30635089

P2093author name stringXue Han
Matthew D Vesely
P2860cites workTargeting CD137 enhances the efficacy of cetuximab.Q33872482
P921main subjectmonoclonal antibodyQ422248
P304page(s)1-25
P577publication date2018-08-20
P1433published inInternational Review of Cell and Molecular BiologyQ26842011
P1476titleStimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies
P478volume342

Reverse relations

cites work (P2860)
Q90212066Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
Q103001166Detection of immunogenic cell death and its relevance for cancer therapy
Q91750826Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
Q99552010Trial watch: STING agonists in cancer therapy

Search more.